| Pharmaceuticals Industry | Healthcare Sector | Michael Kazley CEO | OTCQB Exchange | 66987P508 CUSIP |
| US Country | 4 Employees | 30 Sep 2025 Last Dividend | 23 Feb 2026 Last Split | - IPO Date |
Stablecoin Development Corp. is a pioneering company dedicated to the advancement and commercialization of scientifically-developed and clinically-validated products in the eye care and skin care sectors. Established on January 19, 2000, and headquartered in Emeryville, California, the company has positioned itself as a leader in innovation, utilizing cutting-edge scientific research to create products that enhance health and well-being. The company's commitment to quality and efficacy is reflected in its portfolio, which includes a range of solutions designed to address various healthcare needs in both the dermatological and ophthalmic fields.
Avenova is an advanced topical solution specifically formulated for eyelid hygiene. This product is clinically proven to effectively cleanse and refresh the eyelids while eliminating bacteria and debris. Designed for individuals suffering from conditions like blepharitis, Avenova provides a soothing experience that helps promote overall eye health.
NeutroPhase is a unique, scientifically-formulated cleanser that targets skin conditions requiring a gentle yet effective treatment. Utilizing a proprietary technology, it aids in the removal of impurities and supports the healing of skin, making it an ideal choice for patients with acne, eczema, or other dermatological concerns. Its biocompatible formula ensures safety and effectiveness for a variety of skin types.
DERMAdoctor offers a wide range of skincare products developed to address specific skin concerns such as dryness, pigmentation, and aging. Each product is backed by clinical research, ensuring that consumers receive solutions tailored to their individual needs. This brand emphasizes efficacy and quality, delivering remarkable results to users looking for effective dermatological care.